Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CHANTIX
- Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.
- V+PSF-M for Tobacco Cessation in HIV Care in India
- Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans
- Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
- Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- Varenicline For Vaping Cessation In Non Smoker Vaper Adolescents
- Metabolism Informed Smoking Treatment: The MIST RCT
- STARS (Smoking Treatment And Remote Sampling) Study
- Financial Incentives for Homeless Smokers: A Community-based RCT
- Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3])
- Feasibility of Treatment for Vaping Cessation
- Cannabis and Tobacco Co-use Study
- Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction
- Health Systems Reach Interventions Project
- Combining Varenicline and Guanfacine for Smoking Cessation
- Mobile Health Interventions for Medication Adherence Among PLWH
- Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment
- Optimizing Tobacco Use Treatment for PLWHA
- Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)
- Study to Evaluate the Relative Bioavailability of Varenicline Administered as OC-01 (Varenicline) Nasal Spray as Compared to Varenicline Administered Orally as Chantix®
- UH3 Varenicline for Cannabis Use Disorder
- Individualizing Pharmacotherapy for African American Smokers
- Hollings Cancer Center Varenicline Sampling Study
- Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)
- Varenicline OTC Trial on Efficacy and Safety
- PRecision Interventions for SMoking in the SCCS
- Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
- A Trial of Directly Observed and Long-term Varenicline
- EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking
- Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers
- UW Quitting Using Intensive Treatment Study (QUITS)
- Stage Ib Trial of mSMART With Varenicline
- Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
- Human Laboratory Study of Varenicline for Alcohol Use Disorder
- Treating Smokeless Tobacco Use in Rural Veterans
- Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3
- Smoking Cessation Intervention in Respiratory Inpatients
- Varenicline Treatment for Cannabis Use Disorder
- Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation
- Smoking Cessation & Opioid Dependence Treatment Integration
- Extended Varenicline Treatment for Smoking Among Cancer Patients
- Combining Varenicline and Naltrexone for Smoking Cessation
- Pre to Postoperative Smoking Cessation
- UW-CTRI Triple Medication Smoking Cessation Study
- Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?
- Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
- Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation
- Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)
- Adaptive Pharmacotherapy for Smoking Cessation
- Addressing Post Cessation Weight Gain
- Lorcaserin for Preventing Weight Gain Among Smokers
- Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers
- Advancing Tobacco Use Treatment for African American Smokers
- Genetically Informed Smoking Cessation Trial
- Varenicline and Combined NRT for Smoking Cessation
- Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence
- Varenicline + Prazosin for Heavy Drinking Smokers
- Reward Sensitivity and Pharmacotherapy for Smoking Cessation
- New Approaches to Smoking Cessation in Heavy Drinkers
- My Mobile Advice Program: A Randomized Pilot Feasibility Study
- Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS
- Improving Adherence to Smoking Cessation Medication Among PLWHA
- Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers
- Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers
- Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
- Extended Varenicline Treatment for Smoking Among Cancer Patients
- Varenicline for Nicotine Dependence Among Those With HIV/AIDS
- A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence
- Varenicline for Light Smokers
- Varenicline on Reward Responses and Cognition in Adolescent Smokers
- Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling
- Tailored Tobacco Quitline for Rural Veterans
- Varenicline as a Treatment for Methamphetamine Dependence
- Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants
- Varenicline Treatment of Alcohol Dependence in Smokers
- Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)
- Brain Nicotine Receptor Density & Response to Nicotine Patch
- Effects of Varenicline on Smoking Reminders
- Varenicline for Adolescent Smoking Cessation
- Pilot Study of Varenicline to Treat Opioid Dependence
- Varenicline In-Patient Study
- Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
- Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients
- Varenicline for Methamphetamine Dependence
- Varenicline Treatment for Active Alcoholic Smokers
- Varenicline for Gait and Balance Impairment in Parkinson Disease
- Pharmacogenetics of Nicotine Addiction Treatment
- Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment
- Concurrent Bupropion / Varenicline for Smoking Cessation
- Varenicline Pregnancy Cohort Study
- Varenicline in Drug Treatment
- Effectiveness of Varenicline: Testing Individual Differences
- Tailoring Varenicline to Individual Needs (TVIN Study)
- Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study)
- Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome
- Varenicline and Alcohol in Inpatient Addictions Program (IAP)
- Maintaining Nonsmoking
- Human Behavioral Pharmacology Laboratory (HBPL) Study of Varenicline's Impact on Cocaine and Alcohol Craving
- Varenicline for Alcohol Dependence
- Human Behavioral Pharmacology Laboratory Study of Varenicline's Impact on Cocaine Reinforcement
- Smoking Termination Opportunity for inPatients
- Varenicline and Smoking Cessation in Schizophrenia
- Smoking Cessation Treatment for Head & Neck Cancer Patients
- Efficacy of Varenicline for Smokeless Tobacco Use in India
- Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia
- Smoking Cessation Treatment for Methadone Maintenance Patients
- A Pilot Clinical Trial of Varenicline as a Treatment for Alcohol Dependence
- Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
- Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders
- Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)
- Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
- Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease
- Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease
- Effects of Chantix on Relapse Prevention for Smoking Cessation
- Measuring Smoking Behaviors While Using Varenicline
- Relapse Prevention With Varenicline
- Combining Varenicline and Bupropion for Smoking Cessation
- Treatment of Smoking Among Individuals With PTSD
- Varenicline and Bupropion for Smoking Cessation
- Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers
- Smoking Cessation Treatment for Head and Neck Cancer Patients
- Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)
- Assessing the Impact of Varenicline on Brain-Behavior Vulnerability
- Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
- Smoking Study With Behavioral Therapy for Hypertensive Patients
- Effect of Varenicline on Reactivity to Smoking and Drinking Cues
- Varenicline for Smoking Cessation in Heavy Drinking Smokers
- Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?
- An Alternative Dosing Schedule of Varenicline for Smoking Cessation
- Varenicline for the Treatment of Smokeless Tobacco
- Varenicline in Bipolar Depressed Patients
- Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
- Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
- Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal
- Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
- The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse
- Varenicline and Motivational Advice for Smokers With Substance Use Disorders
- Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence
- Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement
- A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia
- Varenicline-Methamphetamine Interaction Study (2008)
- Effects of Varenicline on Cigarette Self Administration
- Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia
- Human Laboratory Study Of Varenicline in Smokers
- Varenicline (Chantix™) for the Treatment of Alcohol Dependence
- Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)
- Smoking Cessation Using Motivational Therapy and Varenicline
- Endothelial Function and Autonomic Regulation After Short-term Smoking Cessation: Varenicline Versus Placebo
- Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity
- A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.
- A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
- Varenicline and Nicotine Interactions in Humans (VA)
- Effects of Varenicline on Brain Activity During Nicotine Abstinence
- Efficacy of Varenicline in Ambivalent Smokers
- Chantix & Bupropion for Smoking Cessation
- The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior
- Do Treatments for Smoking Cessation Affect Alcohol Drinking?
- Smoking Cessation Intervention for Thoracic Patients
- Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt
- Efficacy of Varenicline in Methadone-Stabilized Cocaine Users
- Chantix for Treating Cocaine Dependence
- Varenicline Effects In Schizophrenic Smokers
- Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers
- Pharmacogenetics, Emotional Reactivity and Smoking
- Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
- Varenicline Adjunctive Treatment in Schizophrenia
- Study of the Effects of Mecamylamine and Varenicline in Schizophrenia
Clinical trials list
click for details